Pathophysiology And Management Of Sickle Cell Disease: New Therapeutic Approaches And Disease-Modifying Treatments. (2022). Journal of Pharmaceutical Negative Results, 13(4), 2305-2310. https://doi.org/10.47750/ceg2qf48